On 3rd June 2025 the PM Society is gathering senior industry and agency leaders together at the Royal Society of Medicine to better understand the challenges of industry and agency to ensure we continue to put strategic rigour at the heart of the pharmaceutical industry’s success.
Insights from the 2024 round table discussions led by our industry-agency relationships interest group confirmed a shared determination across the sector to evolve business models in a way that drives greater impact for both shareholders and patients.
As pipelines expand and economic pressures intensify, the challenge is no longer innovation alone – it’s ensuring commercial viability and relevance in increasingly complex, global markets.
The purpose of our closed-door summit is to bring together senior leaders that can facilitate change. It will provide a rare opportunity for candid conversation among peers facing similar strategic challenges. The intimate format ensures meaningful dialogue rather than superficial networking, with discussions held under Chatham House Rules to encourage open and honest exchange.
This is an invitation only event, but if you want to register your interest in attending or being involved in the interest group going forwards, please email Rachel.